Liquid Biopsy Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Liquid Biopsy Market- Key Findings, 2020

3. Strategic Imperatives on Global Liquid Biopsy Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Liquid Biopsy Companies

4.Liquid Biopsy Market Value Outlook to 2026 Outlook By Circulating Biomarker

• 4.1 Extracellular Vesicles (Evs)
• 4.2 Circulating Tumor Cells
• 4.3 Circulating Tumor DNA (CTDNA)
• 4.4 Cell-Free DNA
• 4.5 Other Circulating Biomarkers

5. Liquid Biopsy Market Value Outlook to 2026 Outlook By Product and Service

• 5.1 Instruments
• 5.2 Assay Kits
• 5.3 Services

6. Liquid Biopsy Market Value Outlook to 2026 Outlook By Application

• 6.1 Non-Cancer Applications
• 6.2 Cancer Applications
  • 6.2.1 Lung Cancer
  • 6.2.2 Liver Cancer
  • 6.2.3 Breast Cancer
  • 6.2.4 Prostate Cancer
  • 6.2.5 Colorectal Cancer
  • 6.2.6 Other Cancers

7. Liquid Biopsy Market Value Outlook to 2026 Outlook By Clinical Application

• 7.1 Treatment Monitoring
• 7.2 Recurrence Monitoring
• 7.3 Early Cancer Screening
• 7.4 Therapy Selection

8. Liquid Biopsy Market Value Outlook to 2026 Outlook By Technology

• 8.1 Multi-gene-parallel Analysis (NGS)
• 8.2 Single Gene Analysis (PCR Microarrays)

9. Liquid Biopsy Market Value Outlook to 2026 Outlook By End User

• 9.1 Hospitals and Physician Laboratories
• 9.2 Academic and Research Centers
• 9.3 Reference Laboratories
• 9.4 Other End Users

10 Asia Pacific Liquid Biopsy Market Value Outlook to 2026

• 10.1 Leading Liquid Biopsy Types contributing to Asia Pacific market
• 10.2 Top Applications contributing to Asia Pacific Liquid Biopsy
• 10.3 Top countries contributing to Asia Pacific Liquid Biopsy

11 Europe Liquid Biopsy Market Value Outlook to 2026

• 11.1 Leading Liquid Biopsy Types contributing to Europe market
• 11.2 Top Applications contributing to Europe Liquid Biopsy
• 11.3 Top countries contributing to Europe Liquid Biopsy

12 North America Liquid Biopsy Market Value Outlook to 2026

• 12.1 Leading Liquid Biopsy Types contributing to North America market
• 12.2 Top Applications contributing to North America Liquid Biopsy
• 12.3 Top countries contributing to North America Liquid Biopsy

13 South and Central America Liquid Biopsy Market Value Outlook to 2026

• 13.1 Leading Liquid Biopsy Types contributing to South and Central America market
• 13.2 Top Applications contributing to South and Central America Liquid Biopsy
• 13.3 Top countries contributing to South and Central America Liquid Biopsy

14 Middle East Africa Liquid Biopsy Market Value Outlook to 2026

• 14.1 Leading Liquid Biopsy Types contributing to Middle East Africa market
• 14.2 Top Applications contributing to Middle East Africa Liquid Biopsy
• 14.3 Top countries contributing to Middle East Africa Liquid Biopsy

15 Business Profiles of Leading Companies

• 15.1 Business Description, SWOT and Financial Analysis of Companies in Liquid Biopsy market
• 15.2 Bio-Rad Laboratories, Inc.
• 15.3 Biocept, Inc.
• 15.4 Genomic Health, Inc.
• 15.5 Menarini-Silicon Biosystems
• 15.6 Myriad Genetics, Inc
• 15.7 Qiagen N.V.
• 15.8 Raindance Technologies, Inc
• 15.9 Roche Diagnostics
• 15.10 Thermo Fisher Scientific Inc.
• 15.11 Trovagene, Inc.

16 Recent Industry Developments

17 Appendix

• 17.1 OGAnalysis Expertise
• 17.2 Sources and Methodology